11Q DELETION ATM (CLL) / HEPARIN BONE MARROW

image not found

The 11q Deletion ATM (CLL) Test using heparinized bone marrow at Metropolis Healthcare detects the deletion of the ATM gene on chromosome 11 in patients with chronic lymphocytic leukemia (CLL). This chromosomal abnormality helps assess disease prognosis and progression. Identifying 11q deletion is important for guiding personalized treatment strategies. The test provides insights into the patient’s risk profile and therapy response. It supports informed clinical decisions and monitoring of CLL patients.

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 5,195.00

Sample Type: HEPARIN BONE MARROW

Fasting Not Required


Booking Procedure:
  1. Technician from Metropolis will be assigned for a free home sample collection after booking confirmation.
  2. Sample will be collected by our technician at your address at given slot.
  3. You will get a payment link in 2 hours. You can make the payment online or pay cash to the technician.
  4. Soft copy reports will be sent to your email address within 24 to 48 hours.

Frequently Asked Questions (FAQ's):

1. What is the 11q Deletion ATM (CLL) Test using heparinized bone marrow?
This test detects the deletion of the ATM gene on chromosome 11 in patients with CLL using a heparin-treated bone marrow sample for precise analysis.

2. Why is this test important?
It helps predict disease progression, assess prognosis, and guide personalized treatment plans in CLL patients.

3. Who should undergo this test?
Patients diagnosed with or suspected of having chronic lymphocytic leukemia (CLL) may be advised to take this test.

4. How is the test performed?
At Metropolis Healthcare, a heparinized bone marrow sample is collected and analyzed using advanced cytogenetic and molecular techniques for accurate detection.

5. What do the results indicate?
Detection of 11q deletion provides information about disease severity, prognosis, and treatment response, while absence suggests other CLL variants.

6. Are there any risks associated with the test?
The test is safe, with minimal risk mainly related to bone marrow sample collection.

7. Why choose Metropolis Healthcare for this test?
Metropolis Healthcare provides accurate genetic testing with advanced technology and expert analysis, ensuring reliable results for effective management of CLL.

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab